Back to Treatments

Treatment

COMT Inhibitors (e.g., Entacapone)

1
Conditions
50
Trials
10K
Participants
65%
Average Safety

Condition Evidence

Parkinson's disease

50 trials · 10K participants

65% effectiveness · 65% safety
COMT Inhibitors (e.g., Entacapone) | DFDA